164 related articles for article (PubMed ID: 23274770)
1. In vitro evaluation of cytochrome P450 induction and the inhibition potential of mitragynine, a stimulant alkaloid.
Lim EL; Seah TC; Koe XF; Wahab HA; Adenan MI; Jamil MF; Majid MI; Tan ML
Toxicol In Vitro; 2013 Mar; 27(2):812-24. PubMed ID: 23274770
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L.
Koe XF; Lim EL; Seah TC; Amanah A; Wahab HA; Adenan MI; Sulaiman SF; Tan ML
Food Chem Toxicol; 2013 Oct; 60():98-108. PubMed ID: 23876819
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 inhibition activities of non-standardized botanical products.
Abduraman MA; Mustafa NH; Yaacob NS; Amanah A; Tan ML
J Ethnopharmacol; 2022 Oct; 296():115406. PubMed ID: 35659627
[TBL] [Abstract][Full Text] [Related]
4. A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator - an in vitro and in vivo comparison.
Zhou D; Sunzel M; Ribadeneira MD; Smith MA; Desai D; Lin J; Grimm SW
Br J Clin Pharmacol; 2012 Jul; 74(1):98-108. PubMed ID: 22122233
[TBL] [Abstract][Full Text] [Related]
5. Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells.
Wang QL; Wu Q; Tao YY; Liu CH; El-Nezami H
Hepatobiliary Pancreat Dis Int; 2011 Oct; 10(5):502-8. PubMed ID: 21947724
[TBL] [Abstract][Full Text] [Related]
6. An 'all-inclusive' 96-well cytochrome P450 induction method: measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes.
Halladay JS; Wong S; Khojasteh SC; Grepper S
J Pharmacol Toxicol Methods; 2012; 66(3):270-5. PubMed ID: 22809809
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
[TBL] [Abstract][Full Text] [Related]
8. Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes.
Han SY; Zhao HY; Zhou N; Zhou F; Li PP
J Ethnopharmacol; 2014; 151(1):210-7. PubMed ID: 24157377
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies of berberine metabolism and its effect of enzyme induction on HepG2 cells.
Cui HM; Zhang QY; Wang JL; Chen JL; Zhang YL; Tong XL
J Ethnopharmacol; 2014 Dec; 158 Pt A():388-96. PubMed ID: 25456436
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepines medazepam and midazolam are activators of pregnane X receptor and weak inducers of CYP3A4: investigation in primary cultures of human hepatocytes and hepatocarcinoma cell lines.
Vrzal R; Kubesova K; Pavek P; Dvorak Z
Toxicol Lett; 2010 Mar; 193(2):183-8. PubMed ID: 20080160
[TBL] [Abstract][Full Text] [Related]
11. Bioactive components of Glycyrrhiza uralensis mediate drug functions and properties through regulation of CYP450 enzymes.
Chen H; Zhang X; Feng Y; Rui W; Shi Z; Wu L
Mol Med Rep; 2014 Sep; 10(3):1355-62. PubMed ID: 24939038
[TBL] [Abstract][Full Text] [Related]
12. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
J Ethnopharmacol; 2010 Jul; 130(2):275-83. PubMed ID: 20457244
[TBL] [Abstract][Full Text] [Related]
13. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
[TBL] [Abstract][Full Text] [Related]
14. New Screening Criteria Setting on Evaluation of Cytochrome P450 Induction Using HepaRG Cells with Multiplex Branched DNA Technologies in Early Drug Discovery.
Ogasawara A; Torimoto N; Tsuda N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
Drug Metab Lett; 2016; 10(3):152-160. PubMed ID: 27550199
[TBL] [Abstract][Full Text] [Related]
15. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
Lim HK; Duczak N; Brougham L; Elliot M; Patel K; Chan K
Drug Metab Dispos; 2005 Aug; 33(8):1211-9. PubMed ID: 15860655
[TBL] [Abstract][Full Text] [Related]
16. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
Yeung JH; Or PM
Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191
[TBL] [Abstract][Full Text] [Related]
17. Andrographolide and 14-deoxy-11, 12-didehydroandrographolide inhibit cytochrome P450s in HepG2 hepatoma cells.
Ooi JP; Kuroyanagi M; Sulaiman SF; Muhammad TS; Tan ML
Life Sci; 2011 Feb; 88(9-10):447-54. PubMed ID: 21219911
[TBL] [Abstract][Full Text] [Related]
18. Bush mint (Hyptis suaveolens) and spreading hogweed (Boerhavia diffusa) medicinal plant extracts differentially affect activities of CYP1A2, CYP2D6 and CYP3A4 enzymes.
Ekow Thomford N; Dzobo K; Adu F; Chirikure S; Wonkam A; Dandara C
J Ethnopharmacol; 2018 Jan; 211():58-69. PubMed ID: 28942133
[TBL] [Abstract][Full Text] [Related]
19. Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes.
Roymans D; Van Looveren C; Leone A; Parker JB; McMillian M; Johnson MD; Koganti A; Gilissen R; Silber P; Mannens G; Meuldermans W
Biochem Pharmacol; 2004 Feb; 67(3):427-37. PubMed ID: 15037195
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice.
Felmlee MA; Lon HK; Gonzalez FJ; Yu AM
Drug Metab Dispos; 2008 Feb; 36(2):435-41. PubMed ID: 18048490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]